ITRM930286A0 - Composizione farmaceutica per somministrazione rettale nel trattamentodi cefaleo e relativo metodo di preparazione ed impiego. - Google Patents

Composizione farmaceutica per somministrazione rettale nel trattamentodi cefaleo e relativo metodo di preparazione ed impiego.

Info

Publication number
ITRM930286A0
ITRM930286A0 IT93RM286A ITRM930286A ITRM930286A0 IT RM930286 A0 ITRM930286 A0 IT RM930286A0 IT 93RM286 A IT93RM286 A IT 93RM286A IT RM930286 A ITRM930286 A IT RM930286A IT RM930286 A0 ITRM930286 A0 IT RM930286A0
Authority
IT
Italy
Prior art keywords
headache
preparation
treatment
pharmaceutical composition
rectal administration
Prior art date
Application number
IT93RM286A
Other languages
English (en)
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of ITRM930286A0 publication Critical patent/ITRM930286A0/it
Publication of ITRM930286A1 publication Critical patent/ITRM930286A1/it
Application granted granted Critical
Publication of IT1261471B publication Critical patent/IT1261471B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
ITRM930286A 1992-05-07 1993-05-06 Composizione farmaceutica per somministrazione rettale nel trattamentodi cefalea e relativo metodo di preparazione ed impiego. IT1261471B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (3)

Publication Number Publication Date
ITRM930286A0 true ITRM930286A0 (it) 1993-05-06
ITRM930286A1 ITRM930286A1 (it) 1994-11-06
IT1261471B IT1261471B (it) 1996-05-23

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM930286A IT1261471B (it) 1992-05-07 1993-05-06 Composizione farmaceutica per somministrazione rettale nel trattamentodi cefalea e relativo metodo di preparazione ed impiego.

Country Status (33)

Country Link
US (1) US5705506A (it)
EP (1) EP0639072B1 (it)
JP (1) JPH07506570A (it)
KR (1) KR100253111B1 (it)
AT (1) ATE163850T1 (it)
AU (1) AU670083B2 (it)
BE (1) BE1007024A5 (it)
BG (1) BG62120B1 (it)
BR (1) BR1100108A (it)
CA (1) CA2135179C (it)
CH (1) CH685920A5 (it)
CY (1) CY2039B1 (it)
CZ (1) CZ283512B6 (it)
DE (1) DE69317418T2 (it)
ES (1) ES2113533T3 (it)
FR (1) FR2690847B1 (it)
GB (2) GB9209882D0 (it)
GR (1) GR3026584T3 (it)
HK (1) HK95697A (it)
HU (2) HU227338B1 (it)
IE (1) IE75203B1 (it)
IL (1) IL105468A (it)
IT (1) IT1261471B (it)
NO (1) NO306700B1 (it)
NZ (1) NZ252132A (it)
OA (1) OA10109A (it)
RO (1) RO112993B1 (it)
RU (1) RU2118527C1 (it)
SG (1) SG46649A1 (it)
TW (1) TW231970B (it)
UA (1) UA37206C2 (it)
WO (1) WO1993021916A1 (it)
ZA (1) ZA933178B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
DK1064942T3 (da) * 1998-03-26 2004-11-01 Fujisawa Pharmaceutical Co Sustained release-fremstilling af et makrolid
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
EP2124556B1 (en) 2006-10-09 2014-09-03 Charleston Laboratories, Inc. Pharmaceutical compositions
ES2620672T3 (es) 2008-01-09 2017-06-29 Charleston Laboratories, Inc. Comprimidos de doble capa que comprenden oxicodona y prometazina
WO2011006012A1 (en) 2009-07-08 2011-01-13 Charleston Laboratories Inc. Pharmaceutical compositions
RU2611376C2 (ru) 2010-10-15 2017-02-21 Контера Фарма Апс Фармацевтическая композиция для лечения, профилактики или облегчения двигательных расстройств и ее применение
NZ700474A (en) 2012-04-18 2016-10-28 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
JP2019507181A (ja) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ,インコーポレイテッド 医薬組成物
AU2017297718B2 (en) 2016-07-11 2023-06-08 Contera Pharma A/S Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
NL8103764A (nl) * 1980-08-12 1982-03-01 Glaxo Group Ltd Heterocyclische verbindingen, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
IT1181741B (it) * 1984-12-04 1987-09-30 Glaxo Group Ltd Derivati di indolo,procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
EP0303507B1 (en) * 1987-08-13 1993-07-28 Glaxo Group Limited Indole derivatives
PT97888B (pt) * 1990-06-07 1998-12-31 Zeneca Ltd Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
CA2135179C (en) 2000-12-05
IL105468A0 (en) 1993-08-18
HUT71418A (en) 1995-11-28
ES2113533T3 (es) 1998-05-01
FR2690847B1 (fr) 1995-06-09
HU227338B1 (en) 2011-04-28
IL105468A (en) 1998-09-24
DE69317418D1 (de) 1998-04-16
EP0639072B1 (en) 1998-03-11
GB2266665A (en) 1993-11-10
BR1100108A (pt) 1999-12-07
GB9209882D0 (en) 1992-06-24
CZ272394A3 (en) 1995-10-18
RO112993B1 (ro) 1998-03-30
NO944214L (no) 1994-11-07
BG62120B1 (bg) 1999-03-31
HU211638A9 (en) 1995-12-28
GR3026584T3 (en) 1998-07-31
FR2690847A1 (fr) 1993-11-12
ATE163850T1 (de) 1998-03-15
HK95697A (en) 1997-08-08
JPH07506570A (ja) 1995-07-20
AU4064093A (en) 1993-11-29
CY2039B1 (en) 1998-04-30
IE930339A1 (en) 1993-11-17
IT1261471B (it) 1996-05-23
IE75203B1 (en) 1997-08-27
WO1993021916A1 (en) 1993-11-11
AU670083B2 (en) 1996-07-04
EP0639072A1 (en) 1995-02-22
ZA933178B (en) 1994-01-10
US5705506A (en) 1998-01-06
NZ252132A (en) 1996-09-25
GB9309209D0 (en) 1993-06-16
GB2266665B (en) 1996-05-22
CZ283512B6 (cs) 1998-04-15
CA2135179A1 (en) 1993-11-11
BG99167A (bg) 1995-06-30
ITRM930286A1 (it) 1994-11-06
RU2118527C1 (ru) 1998-09-10
CH685920A5 (fr) 1995-11-15
KR100253111B1 (en) 2000-07-01
DE69317418T2 (de) 1998-07-30
TW231970B (it) 1994-10-11
BE1007024A5 (fr) 1995-02-21
NO944214D0 (no) 1994-11-04
OA10109A (en) 1996-12-18
UA37206C2 (uk) 2001-05-15
SG46649A1 (en) 1998-02-20
NO306700B1 (no) 1999-12-13

Similar Documents

Publication Publication Date Title
ITBO910476A0 (it) -formulazioni farmeceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali.
EE04021B1 (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
DE3689384D1 (de) Arzneimittel zur topischen Anwendung.
FI903845A7 (fi) Reniini-inhibiittoreita, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeissä
FI952230L (fi) Uusi aryylipropaanijohdannainen, menetelmä sen valmistamiseksi ja sen käyttö analgeettisena aineena
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
FI915970A7 (fi) Lääkkeitä, jotka ovat hyödyllisiä syövän hoidossa ja joilla on antihis tamiiniominaisuuksia
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
FI945975L (fi) Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
FI963883A7 (fi) Farmaseuttisia valmisteita ja lääkeaineita endoteelin toimintahäiriön ehkäisemiseksi ja hoitamiseksi
ITRM930286A0 (it) Composizione farmaceutica per somministrazione rettale nel trattamentodi cefaleo e relativo metodo di preparazione ed impiego.
NL193217B (nl) 1-Methyl-5-p-toluoyl-2-pyrroolaceetamidederivaat met ontstekingsremmende en analgetische eigenschappen en farmaceutisch preparaat dat het bevat.
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
BR9302389A (pt) Composto,formulacao farmaceutica e processo para preparar o composto
IT7925706A0 (it) Uso di glicerilfosforilderivati nella terapia di dislipemie ed epatiti, e composizioni farmaceutiche relative.
FI956353L (fi) Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa
IT1190042B (it) Alchil o aralchil tio-2 cicloalchene 1 carbossammidi 1 e loro solfossidi,procedimenti per la loro preparazione e loro applicazione nella sintesi di tri e tetrametilen-4,5 isotiazolin-4 oni-3
IT8519907A0 (it) Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea.
BR9610851A (pt) Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto
ITRM920305A0 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
ITRM910963A0 (it) Composizione farmaceutica effervescente anticefalalgica e metodo per prepararla ed applicarla.
IT8219012A0 (it) Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
ITRM930183A0 (it) Metodo di terapia, in particolare di terapia estetica, sostanze in gelo crema per esaltare l'effetto del trattamento ed apparecchiatura relativa per l'applicazione del metodo.
IT8619457A0 (it) Derivati insaturi cicloalifatici, loro procedimenti di prepatazione e loro impiego in terapia e in cosmetica.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970530